“ Iris and Tom Vincent of Prime Air Corp explain the challenges behind providing logistics solutions to manufacturers in Puerto Rico, and how their non-stop service allows… ”
In Conversation
“ Nilsa Martinez, general manager of Pace Analytical Puerto Rico, outlines the affiliate’s services in microbiology and chemistry analysis as a critical service provider to the local… ”
“ John O’Hara is the general manager and vice president of Janssen’s facilities in Puerto Rico as well as the head of the Janssen campus. He discusses… ”
“ José Pérez de Gracia, president of Farmacias Plaza, discusses the environment between multinational chains and local pharmacies as well as his own plan for extended growth… ”
“ Prevention versus remediation is the name of the game in regulatory and compliance issues for pharmaceutical manufacturers; the cost of non-compliance is much higher than investing… ”
“ Daneris Fernández, CEO and president of DGF Consulting Group, outlines the firm’s services that help Latin American companies enter Puerto Rico as well as its focus… ”
“ Miguel Centeno, general manager and head of Roche Diabetes Care in Puerto Rico, highlights the affiliate’s strong manufacturing performance in the area of diabetes care (DC)… ”
“ IMS Health recently released its World Review 2015. ”
Interview: Pablo Dávila – President, Mexican Association of Innovative Medical Device Industries (AMID)
“ The industry of medical devices is still not very well understood. ”
Interview: Salvador Berrios Vides – Managing Director & Graciela Aguilar Gil Samaniego – Technical & RA Director, Qually – Mexico
“ The technical & RA director and the managing director of Qually Corporacion explain how authorized third partied act as an extension of the regulative body, Cofepris,… ”
“ The managing director of MSD in Mexico explains why the Mexican pharmaceutical market is an attractive market in which to compete, but not one that will… ”
“ Claudio Soto, general manager of PAREXEL Mexico, discusses how the clinical research process required to receive approval for a new clinical protocol in Mexico is fairly… ”